Real-world persistence of bictegravir versus dolutegravir single-tablet regimens: A retrospective cohort study in a large urban Canadian HIV clinic.

Int J STD AIDS · 2026 · PMC12783377 · PMID 40853039

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similarly, the discontinuation difference in the RPV/DTG subgroup did not reach statistical significance (HR: 1.37; 95% CI: 0.90–2.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.